1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engaging the radiology community in the National Clinical Trials Network: The ECOG-ACRIN TMIST experience
    Meeting Abstract

    Pisano, E.; Gatsonis, C.; Schnall, M. D.; Yaffe, M.; Troester, M. A.; Gareen, I. F.; Collins, L. C.; Curtis, A.; Cole, E.; Cormack, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • NRG-RTOG 1106/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC-Results and comparison to NRG-RTOG 0617 (non-personalized RT dose escalation)
    Meeting Abstract

    Kong, F. M. S.; Hu, C.; Ten Haken, R.; Xiao, Y.; Matuszak, M.; Hirsh, V.; Pryma, D. A.; Siegel, B. A.; Gelblum, D. Y.; Hayman, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and cost-effectiveness of breast cancer (BC) screening in female survivors of childhood Hodgkin lymphoma (HL)
    Meeting Abstract

    Wong, F. L.; Lee, J. M.; Leisenring, W. M.; Neglia, J. P.; Howell, R. M.; Smith, S. A.; Oeffinger, K. C.; Moskowitz, C. S.; Henderson, T. O.; Mertens, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy of clinical breast examination in chest-irradiated female survivors of childhood Hodgkin lymphoma (HL)
    Meeting Abstract

    Wong, F. L.; Lee, J. M.; Leisenring, W. M.; Neglia, J. P.; Howell, R. M.; Smith, S. A.; Oeffinger, K. C.; Moskowitz, C. S.; Henderson, T. O.; Mertens, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of immune checkpoint inhibitor-mediated colitis: Multicenter cohort study
    Meeting Abstract

    Abu-Sbeih, H.; Tang, T.; Faleck, D. M.; Dougan, M. L.; Olsson-Brown, A.; Johnson, D. B.; Owen, D. H.; Warner, D. E.; Philipp, A. B.; Powell, N.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; O'Kane, G. M.; Goto, K.; Kim, D. W.; Neuzillet, C.; Martin-Romano, P.; Duruisseaux, M.; Nagasaka, M.; Rodon, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20)
    Meeting Abstract

    Piotrowska, Z.; Yu, H. A.; Yang, J. C. H.; Koczywas, M.; Smit, E. F.; Tan, D. S. W.; Lee, V. H. F.; Soo, R. A.; Wrangle, J. M.; Spira, A. I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
    Meeting Abstract

    Rogue, D. M.; Bellone, S.; Siegel, E. R.; Buza, N.; Bonazzoli, E.; Guglielmi, A.; Zammataro, L.; Nagarkatti, N.; Zaidi, S.; Lee, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Janne, P. A.; Baik, C. S.; Su, W. C.; Johnson, M. L.; Hayashi, H.; Nishio, M.; Kim, D. W.; Koczywas, M.; Gold, K. A.; Steuer, C. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Intracranial activity of tepotinib in patients (pts) with MET exon 14 (METex14) skipping NSCLC enrolled in VISION
    Meeting Abstract

    Patel, J. D.; Le, X.; Veillon, R.; Anderson, I. C.; Bestvina, C. M.; Demedts, I.; Garassino, M. C.; Mazieres, J.; Morise, M.; Smit, E. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save